510Tip Camrelizumab Combined with Fruquintinib or Regorafenib As Second or Later Line Therapy for BRAF Positive-Mutation Advanced Colorectal Cancer (CRC) with Microsatellite Stability (MSS): A Single-Arm, Phase II Study
Annals of Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined